Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 26, 2026 07:00 ET | Source: Entrada Therapeutics, Inc.

Entrada Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results

Entrada Therapeutics reports financial results for the fourth quarter and full year ended December 31, 2025, and highlights recent business updates.
February 17, 2026 07:00 ET | Source: Entrada Therapeutics, Inc.

Independent Data Monitoring Committee Recommends Initiation of Cohort 2 at the Increased Dose of 12 mg/kg in Entrada Therapeutics’ ELEVATE-44-201 Study

Independent Data Monitoring Committee Recommends Initiation of Cohort 2 at the Increased Dose of 12 mg/kg in Entrada Therapeutics’ ELEVATE-44-201 Study
May 08, 2025 07:00 ET | Source: Entrada Therapeutics, Inc.

Entrada Therapeutics Reports First Quarter 2025 Financial Results

Entrada Therapeutics, Inc. (Nasdaq: TRDA) reports financial results for the first quarter ended March 31, 2025, and highlights recent business updates.